BRIEF-Neubase Therapeutics To Dissolve, Liquidate And Distribute To Stockholders Its Available Assets

Reuters02-24

Feb 23 (Reuters) - NeuBase Therapeutics Inc :

* NEUBASE THERAPEUTICS- ON FEB 22, BOARD DETERMINED FOR COMPANY TO DISSOLVE, LIQUIDATE AND DISTRIBUTE TO STOCKHOLDERS ITS AVAILABLE ASSETS

* NEUBASE THERAPEUTICS INC - HAS BEEN ENGAGED IN AN EVALUATION OF POTENTIAL STRATEGIC AND OTHER ALTERNATIVES

* NEUBASE THERAPEUTICS INC - BOARD UNANIMOUSLY APPROVED LIQUIDATION AND DISSOLUTION OF COMPANY

* NEUBASE THERAPEUTICS INC - BOARD EXPECTS TO, IN NEAR FUTURE APPROVE A FORMAL PLAN OF DISSOLUTION

Source text for Eikon: Further company coverage:

((reuters.briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2413683743?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-02-24 07:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2413683743","market":"us","top_or_hot":-1,"title":"BRIEF-Neubase Therapeutics To Dissolve, Liquidate And Distribute To Stockholders Its Available Assets","media":"Reuters","content":"<html><body><p>Feb 23 (Reuters) - NeuBase Therapeutics Inc   :</p><p>   * NEUBASE THERAPEUTICS- ON FEB 22, BOARD DETERMINED FOR COMPANY TO DISSOLVE, LIQUIDATE AND DISTRIBUTE TO STOCKHOLDERS ITS AVAILABLE ASSETS</p><p>   * NEUBASE THERAPEUTICS INC - HAS BEEN ENGAGED IN AN EVALUATION OF POTENTIAL STRATEGIC AND OTHER ALTERNATIVES</p><p>   * NEUBASE THERAPEUTICS INC - BOARD UNANIMOUSLY APPROVED LIQUIDATION AND DISSOLUTION OF COMPANY</p><p>   * NEUBASE THERAPEUTICS INC -  BOARD EXPECTS TO, IN NEAR <a href=\"https://laohu8.com/S/FUTR.UK\">FUTURE</a> APPROVE A FORMAL PLAN OF DISSOLUTION</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((reuters.briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Neubase Therapeutics To Dissolve, Liquidate And Distribute To Stockholders Its Available Assets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Neubase Therapeutics To Dissolve, Liquidate And Distribute To Stockholders Its Available Assets\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-24 07:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Feb 23 (Reuters) - NeuBase Therapeutics Inc   :   * NEUBASE THERAPEUTICS- ON FEB 22, BOARD DETERMINED FOR COMPANY TO DISSOLVE, LIQUIDATE AND DISTRIBUTE TO STOCKHOLDERS ITS AVAILABLE ASSETS   * NEUBASE...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NBSE","symbol_name":"NeuBase Therapeutics Inc.","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2413683743","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2413683743","pubTimestamp":1708731424,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Feb 23  - NeuBase Therapeutics Inc   :   * NEUBASE THERAPEUTICS- ON FEB 22, BOARD DETERMINED FOR COMPANY TO DISSOLVE, LIQUIDATE AND DISTRIBUTE TO STOCKHOLDERS ITS AVAILABLE ASSETS   * NEUBASE THERAPEUTICS INC - HAS BEEN ENGAGED IN AN EVALUATION OF POTENTIAL STRATEGIC AND OTHER ALTERNATIVES   * NEUBASE THERAPEUTICS INC - BOARD UNANIMOUSLY APPROVED LIQUIDATION AND DISSOLUTION OF COMPANY   * NEUBASE THERAPEUTICS INC -  BOARD EXPECTS TO, IN NEAR FUTURE APPROVE A FORMAL PLAN OF DISSOLUTIONSource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NBSE":"NeuBase Therapeutics Inc.","BK4139":"生物科技"},"translate_title":"简报——Neubase Therapeutics解散、清算并向股东分配其可用资产","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NBSE":0.9},"content_text":"Feb 23 (Reuters) - NeuBase Therapeutics Inc   :   * NEUBASE THERAPEUTICS- ON FEB 22, BOARD DETERMINED FOR COMPANY TO DISSOLVE, LIQUIDATE AND DISTRIBUTE TO STOCKHOLDERS ITS AVAILABLE ASSETS   * NEUBASE THERAPEUTICS INC - HAS BEEN ENGAGED IN AN EVALUATION OF POTENTIAL STRATEGIC AND OTHER ALTERNATIVES   * NEUBASE THERAPEUTICS INC - BOARD UNANIMOUSLY APPROVED LIQUIDATION AND DISSOLUTION OF COMPANY   * NEUBASE THERAPEUTICS INC -  BOARD EXPECTS TO, IN NEAR FUTURE APPROVE A FORMAL PLAN OF DISSOLUTIONSource text for Eikon:    Further company coverage:    ((reuters.briefs@thomsonreuters.com;))","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2413683743"}